Mazor Robotics Ltd. (NASDAQ:MZOR) will be announcing its earnings results before the market opens on Tuesday, November 7th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter.

Mazor Robotics (NASDAQ:MZOR) last announced its quarterly earnings data on Tuesday, August 1st. The medical instruments supplier reported ($0.16) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.25) by $0.09. Mazor Robotics had a negative return on equity of 28.51% and a negative net margin of 37.66%. The firm had revenue of $15.46 million for the quarter, compared to the consensus estimate of $15.38 million. During the same quarter last year, the business posted ($0.09) earnings per share. The firm’s revenue was up 86.7% compared to the same quarter last year. On average, analysts expect Mazor Robotics to post $-0.94 EPS for the current fiscal year and $-0.57 EPS for the next fiscal year.

Shares of Mazor Robotics Ltd. (NASDAQ MZOR) traded up 6.74% during trading on Tuesday, reaching $64.10. The company had a trading volume of 837,795 shares. The firm’s 50 day moving average price is $51.05 and its 200 day moving average price is $41.65. Mazor Robotics Ltd. has a 12 month low of $20.19 and a 12 month high of $65.97. The firm’s market capitalization is $1.55 billion.

MZOR has been the topic of a number of analyst reports. Ladenburg Thalmann Financial Services set a $54.00 target price on Mazor Robotics and gave the company a “buy” rating in a report on Wednesday, August 30th. Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “buy” rating and set a $41.00 target price on the stock in a report on Tuesday, August 15th. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a report on Thursday, July 6th. Finally, Barclays PLC reiterated a “hold” rating and set a $34.00 target price on shares of Mazor Robotics in a report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $39.83.

COPYRIGHT VIOLATION WARNING: “Mazor Robotics Ltd. (MZOR) Scheduled to Post Quarterly Earnings on Tuesday” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Earnings History for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with's FREE daily email newsletter.